SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-005048
Filing Date
2022-04-04
Accepted
2022-04-04 16:05:37
Documents
4
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220517xdef14a.htm DEF 14A 1090042
2 GRAPHIC tmb-20220517xdef14a001.jpg GRAPHIC 4934
3 GRAPHIC tmb-20220517xdef14a010.jpg GRAPHIC 181046
4 GRAPHIC tmb-20220517xdef14a011.jpg GRAPHIC 121443
  Complete submission text file 0001558370-22-005048.txt   1515048
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36721 | Film No.: 22802106
SIC: 2836 Biological Products, (No Diagnostic Substances)